Effectiveness of an influenza A (H1N1) 2009 monovalent vaccine among Japanese pregnant women: A prospective observational study assessing antibody efficacy

Vaccine

Volumn 30, Issue 52, 2012, Pages 7630-7636

  Fukushima, Wakaba ^a   Ohfuji, Satoko ^a   Deguchi, Masaaki ^b   Kawabata, Kazume ^c   Hatayama, Hideaki ^a   Yoshida, Hideki ^d   Maeda, Akiko ^a   Hirota, Yoshio ^a  

^a Osaka Prefecture University   (Japan)

^b Osaka City Juso Hospital   (Japan)

^c Kawabata Women's Clinic   (Japan)

^d National Institute of Infectious Diseases   (Japan)

Author keywords

Antibody efficacy; Effectiveness; Influenza vaccine; Pandemic influenza; Pregnant women

Indexed keywords

INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; DRUG EFFICACY; EPIDEMIC; FEMALE; FIRST TRIMESTER PREGNANCY; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; JAPANESE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANT WOMEN; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870519600     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.027     Document Type: Article

References (44)

1. Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:536-541. Centers for Disease Control and Prevention (CDC).
2. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:321-326. Centers for Disease Control and Prevention (CDC).
3. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
4. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
5. Louie J.K., Acosta M., Jamieson D.J., Honein M.A. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010, 362:27-35. for the California Pandemic (H1N1) Working Group.
6. Creanga A.A., Johnson T.F., Graitcer S.B., Hartman L.K., Al-Samarrai T., Schwarz A.G., et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010, 115:717-726.
7. Siston A.M., Rasmussen S.A., Honein M.A., Fry A.M., Seib K., Callaghan W.M., et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010, 303:1517-1525.
8. Lim M.L., Chong C.Y., Tee W.S., Lim W.Y., Chee J.J. Influenza A/H1N1 (2009) infection in pregnancy-an Asian perspective. BJOG 2010, 117:551-556.
9. Knight M., Pierce M., Seppelt I., Kurinczuk J.J., Spark P., Brocklehurst P., et al. Critical illness with AH1N1v influenza in pregnancy: a comparison of two population-based cohorts. BJOG 2011, 118:232-239.
10. Dede F., Celen S., Bilgin S., Ure G., Ozcan A., Buzgan T., et al. Maternal deaths associated with H1N1 influenza virus infection in Turkey: a whole-of-population report. BJOG 2011, 118:1216-1222.
11. Harris J.W. Influenza occurring in pregnant women. JAMA 1919, 72:978-980.
12. Greenberg M., Jacobziner H., Pakter J., Weisl B.A. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol 1958, 76:897-902.
13. Freeman D.W., Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959, 78:1172-1175.
14. Widelock D., Csizmas L., Klein S. Influenza, pregnancy, and fetal outcome. Public Health Rep 1963, 78:1-11.
15. Mullooly J.P., Barker W.H., Nolan T.F. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986, 101:205-211.
16. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998, 148:1094-1102.
17. Dodds L., McNeil S.A., Fell D.B., Allen V.M., Coombs A., Scott J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007, 176:463-468.
18. Rasmussen S.A., Jamieson D.J., Bresee J.S. Pandemic influenza and pregnant women. Emerg Infect Dis 2008, 14:95-100.
19. Jamieson D.J., Theiler R.N., Rasmussen S.A. Emerging infections and pregnancy. Emerg Infect Dis 2006, 12:1638-1643.
20. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59(RR-8):1-62.
21. ACOG Committee Opinion No. 468: influenza vaccination during pregnancy. Obstet Gynecol 2010, 116:1006-1007. American College of Obstetricians and Gynecologists Committee on Obstetric Practice.
22. Sumaya C.V., Gibbs R.S. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979, 140:141-146.
23. Murray D.L., Imagawa D.T., Okada D.M., St Geme J.W. Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol 1979, 10:184-187.
24. Englund J.A., Mbawuike I.N., Hammill H., Holleman M.C., Baxter B.D., Glezen W.P. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993, 168:647-656.
25. Munoz F.M., Greisinger A.J., Wehmanen O.A., Mouzoon M.E., Hoyle J.C., Smith F.A., et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005, 192:1098-1106.
26. Tamma P.D., Ault K.A., del Rio C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009, 201:547-552.
27. Ohfuji S., Fukushima W., Deguchi M., Kawabata K., Yoshida H., Hatayama H., et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. J Infect Dis 2011, 203:1301-1308.
28. Horiya M., Hisano M., Iwasaki Y., Hanaoka M., Watanabe N., Ito Y., et al. Efficacy of double vaccination with the 2009 pandemic influenza A (H1N1) vaccine during pregnancy. Obstet Gynecol 2011, 118:887-894.
29. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
30. Eick A.A., Uyeki T.M., Klimov A., Hall H., Reid R., Santosham M., et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011, 165:104-111.
31. Benowitz I., Esposito D.B., Gracey K.D., Shapiro E.D., Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010, 51:1355-1361.
32. Poehling K.A., Szilagyi P.G., Staat M.A., Snively B.M., Payne D.C., Bridges C.B., et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011, 204(6 (Suppl. 1)):S141-S148.
33. Black S.B., Shinefield H.R., France E.K., Fireman B.H., Platt S.T., Shay D., et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004, 21:333-339.
34. Longini I.M., Koopman J.S., Haber M., Cotsonis G.A. Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. Am J Epidemiol 1988, 128:845-859.
35. Hirota Y., Kaji M., Ide S., Kajiwara J., Kataoka K., Goto S., et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 1997, 15:962-967.
36. Hara M., Tanaka K., Kase T., Maeda A., Hirota Y. Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan. Vaccine 2010, 28:5664-5668.
37. European Committee for Proprietary Medical Products Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96) 1997, European Agency for the Evaluation of Medical Products, London.
38. Center for Biologics Evaluation and Research Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines 2007, Food and Drug Administration, Bethesda, MD.
39. Hak E., Verheij T.J., Grobbee D.E., Nichol K.L., Hoes A.W. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002, 56:951-955.
40. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344.
41. Fukushima W., Hayashi Y., Mizuno Y., Suzuki K., Kase T., Ohfuji S., et al. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents. Vaccine 2008, 26:6466-6469.
42. Wu J., Zhong X., Li C.K., Zhou J.F., Lu M., Huang K.Y., et al. Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 2011, 29:1009-1016.
43. Uno S., Kimachi K., Kei J., Miyazaki K., Oohama A., Nishimura T., et al. Microbiol Immunol 2011, 55:783-789.
44. Choi Y.S., Baek Y.H., Kang W., Nam S.J., Lee J., You S., et al. Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol 2011, 18:1519-1523.